Published: 25 July, 2022 | Volume 6 - Issue 1 | Pages: 006-008
Figure 1b:
Overall survival (5 years) in the adjuvant treatment of pancreatic cancer patients (n = 28) was 17,9% and the median survival time was 29,4 months.
Read Full Article HTML DOI: 10.29328/journal.acst.1001027 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."